TB diagnosis: latest news

TB diagnosis resources

  • Tuberculosis

    Tuberculosis (TB) is an infection caused by bacteria that usually affects the lungs. With careful treatment it can be cured.TB is the single biggest cause...

    From: Factsheets

    Information level Level 2
  • Diagnosing TB

    Because the symptoms of TB can resemble those of other illnesses seen in people with HIV, doctors will often carry out a number of tests...

    From: Booklets

    Information level Level 2

TB diagnosis features

TB diagnosis in your own words

TB diagnosis news from aidsmap

More news

TB diagnosis news selected from other sources

  • South Africa: Pledge to turn tide in the war on TB

    A massive tuberculosis screening programme to the tune of half a billion rand will begin next month, covering three areas of society most vulnerable to the disease, Health Minister Aaron Motsoaledi said yesterday at a briefing held in Pretoria. Every prisoner in the country will be screened for tuberculosis from next month. If inmates test positive, their families will be tracked and also tested for the disease. There are over 150,000 prisoners in South Africa.

    17 February 2015 | Times Live
  • PHE and NHS England launch joint £11.5m strategy to wipe out TB in the UK

    Public Health England (PHE) and NHS England have today (19 January 2015) announced an £11.5 million investment as part of a collaborative initiative to decrease TB cases and ultimately eliminate TB as a public health problem in England.

    19 January 2015 | Public Health England press release
  • Xpert TB Takes Twice Longer Than Standard TB Test In HIV+ Of Durban

    Xpert MTB/RIF testing for pulmonary tuberculosis in a central lab took twice longer than sputum smear microscopy among HIV-positive patients with suspected pulmonary TB in Durban, South Africa. The authors believe Xpert results in “operational delays that limit the test's clinical utility for diagnosing pulmonary TB” in their patients.

    09 December 2014 | International AIDS Society
  • UNITAID: Tuberculosis diagnostics technology and market landscape – 3rd edition

    UNITAID releases today its 2014 Tuberculosis Diagnostics Technology and Market Landscape, detailing the promising pipeline of products and technologies to diagnose tuberculosis (TB). The report highlights current and emerging technologies from over 80 manufacturers and developers, including products which are smaller, simpler and easier to use.

    01 October 2014 | EATG
  • From Rhetoric to Reality: An Analysis of Efforts to Scale Up The Response to TB-HIV

    A new research report from ACTION global health shows that joint TB-HIV activities are neglected by HIV programs and overwhelmingly carried out by TB programs, and that global guidelines to address TB-HIV have not been prioritized by leading donors and affected countries.

    22 July 2014 | ACTION
  • South Africa: Antiretrovirals Credited for TB Decline

    South Africa is seeing about 79,000 fewer TB cases annually thanks to increased HIV treatment uptake, according to the latest research from the National Institute for Communicable Diseases (NCID)

    13 June 2014 | Health-e
  • Mass TB Tests 'Would Save Billions'

    A World Bank study has estimated that South Africa, Lesotho, Swaziland, and Mozambique could save approximately 13 billion rand a year in increased productivity and reduced TB transmission by spending 330 million rand per year to test and treat miners in the gold and platinum mining industry for TB.

    31 March 2014 | Business Daily
  • Poor Diagnosis Driving Global Multidrug-Resistant TB, WHO Warns

    In 2012, fewer than 25 percent of the 500,000 people with multidrug-resistant TB (MDR TB) infections received a diagnosis, according to the World Health Organization (WHO). As a result, many MDR TB-infected individuals received the wrong treatment or no treatment at all.

    24 March 2014 | Reuters
  • South Africa Battles Drug-Resistant TB

    Despite an increase in diagnosis times, South Africa is facing a growing drug-resistant tuberculosis (TB) burden as nationally there remains a large gap between the number of patients diagnosed with multidrug-resistant TB (MDR-TB) and those who start treatment.

    12 March 2014 | Inter Press Service
  • Xpert TB test doesn’t reduce morbidity but it does have important advantages

    While it is disappointing that the Xpert did not confer a morbidity or mortality benefit, its advantages include quicker and easier diagnosis with less work for health workers.

    10 March 2014 | HIV i-Base
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.